These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31115967)

  • 1. S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018.
    Ugurel S; Kortmann RD; Mohr P; Mentzel T; Garbe C; Breuninger H; Bauer S; Grabbe S
    J Dtsch Dermatol Ges; 2019 Jun; 17(6):663-668. PubMed ID: 31115967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dermatofibrosarcoma protuberans].
    Ugurel S
    Hautarzt; 2008 Nov; 59(11):933-9; quiz 940. PubMed ID: 18936902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Morphea to Dermatofibrosarcoma Protuberans.
    Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatment options for dermatofibrosarcoma protuberans.
    Rutkowski P; Debiec-Rychter M
    Expert Rev Anticancer Ther; 2015; 15(8):901-9. PubMed ID: 26027711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment options in dermatofibrosarcoma protuberans.
    Lemm D; Mügge LO; Mentzel T; Höffken K
    J Cancer Res Clin Oncol; 2009 May; 135(5):653-65. PubMed ID: 19205737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatofibrosarcoma Protuberans.
    Allen A; Ahn C; Sangüeza OP
    Dermatol Clin; 2019 Oct; 37(4):483-488. PubMed ID: 31466588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatofibrosarcoma protuberans: recent clinical progress.
    McArthur G
    Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
    Koseła-Paterczyk H; Rutkowski P
    Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New molecular approaches in dermatofibrosarcoma protuberans].
    Kaya G
    Rev Med Suisse; 2009 Jul; 5(211):1519-24. PubMed ID: 19694363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans.
    Iwasaki T; Yamamoto H; Oda Y
    Curr Treat Options Oncol; 2019 Mar; 20(4):29. PubMed ID: 30874910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.
    Saiag P; Grob JJ; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Stratigos A; Middelton M; Basholt L; Testori A; Garbe C
    Eur J Cancer; 2015 Nov; 51(17):2604-8. PubMed ID: 26189684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
    Llombart B; Serra-Guillén C; Monteagudo C; López Guerrero JA; Sanmartín O
    Semin Diagn Pathol; 2013 Feb; 30(1):13-28. PubMed ID: 23327727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
    Maki RG; Awan RA; Dixon RH; Jhanwar S; Antonescu CR
    Int J Cancer; 2002 Aug; 100(6):623-6. PubMed ID: 12209598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients.
    Wang C; Luo Z; Chen J; Zheng B; Zhang R; Chen Y; Shi Y
    Medicine (Baltimore); 2015 May; 94(17):e773. PubMed ID: 25929918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
    Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
    Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma Protuberans: The Current State of Multidisciplinary Management.
    Ramirez-Fort MK; Meier-Schiesser B; Niaz MJ; Niaz MO; Feily A; Fort M; Lange CS; Caba D
    Skinmed; 2020; 18(5):288-293. PubMed ID: 33160438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
    Thway K; Noujaim J; Jones RL; Fisher C
    Ann Diagn Pathol; 2016 Dec; 25():64-71. PubMed ID: 27806849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatofibrosarcoma Protuberans: What Is This?
    Vitiello GA; Lee AY; Berman RS
    Surg Clin North Am; 2022 Aug; 102(4):657-665. PubMed ID: 35952694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of Patients With Dermatofibrosarcoma Protuberans on Diagnostic Delays, Surgical Outcomes, and Nonprotuberance.
    David MP; Funderburg A; Selig JP; Brown R; Caliskan PM; Cove L; Dicker G; Hoffman L; Horne T; Gardner JM
    JAMA Netw Open; 2019 Aug; 2(8):e1910413. PubMed ID: 31469398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.